Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated 
with haloperidol compared to unmedicated subjects

Dalal, M. A.; Schuld, A.; Pollmächer, T.

Local TagsRelease HistoryDetailsSummary

Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects

Dalal, M. A., Schuld, A., & Pollmächer, T. (2003). Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Pharmacopsychiatry, 36(5), 218-218.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-9E32-1 Version Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-9E33-0

Genre: Journal Article

Alternative Title : Pharmacopsychiatry

Files

show Files

Locators

show

Creators

show

hide

Creators:
Dalal, M. A.¹, Author
Schuld, A.², Author
Pollmächer, T.², Author

Affiliations:
1AG Kimura, Mayumi, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607150
2Max Planck Institute of Psychiatry, Max Planck Society, ou_1607137

Content

show

Details

show

hide

Language(s): eng - English

Dates: Date issued: 2003-09

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: eDoc: 121134
ISI: 000186262800051

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: Pharmacopsychiatry

Alternative Title : Pharmacopsychiatry

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: 36 (5) Sequence Number: - Start / End Page: 218 - 218 Identifier: ISSN: 0176-3679